ContextVision – Arto Järvinen appointed as the new CTO

ContextVision is pleased to announce that Arto Järvinen has been promoted to the company’s CTO position. Järvinen has been Director of R&D since 2011 and has been instrumental in leading the company’s operational R&D work. Järvinen has succeeded the former CTO and co-founder Martin Hedlund. Hedlund retired earlier this year but will resume in his board position for the company.
Read More

ContextVision announces first digital pathology patent granted for its unique and objective data-generation method

Master Annotation method has received patent protection in the U.S. The U.S. Patent and Trademark Office (USPTO) has granted a patent to ContextVision for this invention, titled “method and system for detecting pathological anomalies in a digital pathology image and method for annotating a tissue slide”.
Read More

ContextVision unveils latest innovation in advanced medical imaging

ContextVision unveils latest innovation in advanced medical imaging At this year’s RSNA, ContextVision demonstrates RiventTM, taking image enhancement for ultrasound to a whole new level STOCKHOLM – Nov. 18, 2019 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, provides cutting-edge technology to support clinicians to accurately interpret medical images, […]
Read More

ContextVision – Strong Q3 with solid sales, good inflow of new customers and first product in digital pathology enters beta-testing phase

STOCKHOLM – October 24, 2019 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, has seen a strong third quarter in 2019 as new customers have been added and the first product in digital pathology has entered the beta-testing phase. Q3 sales reached 23 MSEK and total sales are growing […]
Read More

ContextVision AB – Company presentation held in Oslo

Stockholm, September 18th, 2019 – Today ContextVision held a company presentation in Oslo, Norway. The arrangement was held at Norne Securities AS premises at Roald Amundsens gt. 6, Oslo. CEO Fredrik Palm gave an update of the company’s development and shared the company’s future direction. Please find a PDF-version of the presentation attached. The presentation […]
Read More

ContextVision – Company presentations held at Danske Bank Small Cap Day in Stockholm

Stockholm, September 12th, 2019 – Today ContextVision presented the company at Danske Bank’s Small Cap Day in Stockholm, Sweden. CEO Fredrik Palm gave an update of the company’s development and shared the company’s future direction. Please find a PDF-version of the presentation attached. The presentation will also be published on the company’s website. For further […]
Read More

ContextVision AB – Invitation to company presentation

We are pleased to invite you to a presentation of Contextvision AB and its 2nd quarter and six months 2019 figures and give an update on the ongoing projects. The meeting will be held at the offices of Norne Securities AS (Oslo Office), Roald Amundsens gt. 6, Oslo. Wednesday, September 18th at 12.00 Lunch will […]
Read More

ContextVision – Second quarter saw commercial release of first AI-based product, Altumira™, Digital Pathology on track and record sales

STOCKHOLM – August 15, 2019 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, continued to advance its artificial intelligence portfolio in the second quarter 2019. The company’s AI-based product Altumira™ for X-ray is now commercially available and INIFY Prostate for digital pathology will soon move to beta testing in […]
Read More

Company presentation held at Carnegie in Stockholm

Stockholm, June 12th, 2019 – Today ContextVision held a company presentation at Carnegie in Stockholm, Sweden. Fredrik Palm gave an update of the company’s development and shared the company’s future direction. Please find a PDF-version of the presentation here. For further information, please contact ContextVision’s CEO, Fredrik Palm, at +46 76 870 25 43 or […]
Read More